93 related articles for article (PubMed ID: 635510)
1. [Treatment with high-dose beta-pyridylcarbinol: results in patients with hypercholesterinemia].
Mordasini R; Schlumpf E; Nobile PC; Brun del Re G; Riva G
Schweiz Med Wochenschr; 1978 Apr; 108(14):533-8. PubMed ID: 635510
[TBL] [Abstract][Full Text] [Related]
2. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
Mordasini R; Müller A; Klose G; Middelhoff G; Augustin J; Haase W; Greten H
MMW Munch Med Wochenschr; 1978 Apr; 120(15):525-8. PubMed ID: 206826
[TBL] [Abstract][Full Text] [Related]
3. [Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(12):1682-4. PubMed ID: 6686774
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of hypercholesterolemia with beta-pyridylcarbinol. Experiences after long term treatment over 8 years (author's transl)].
Zöllner N; Keller C; Wolfram G
Med Klin; 1976 Apr; 71(18):768-74. PubMed ID: 818496
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)].
Wolfram G; Keller C; Kilani S; Zöllner N
Dtsch Med Wochenschr; 1976 Jan; 101(3):76-81. PubMed ID: 1245160
[TBL] [Abstract][Full Text] [Related]
6. [Drug treatment of hypercholesterolemia. Experience with a combination of dextrothyroxine and betapyridylcarbinol (author's transel)].
Schneider J; Schubotz R; Manteuffel Ev; Kaffarnik H
Med Klin; 1978 Jun; 73(23):874-7. PubMed ID: 661731
[TBL] [Abstract][Full Text] [Related]
7. [Procetophen--an alternative in the treatment of hypercholsterinemia?].
Mordasini R; Grandjean EM; Nobile PC; Paumgartner G; Riva G
Schweiz Med Wochenschr; 1979 Aug; 109(31):1140-3. PubMed ID: 472702
[TBL] [Abstract][Full Text] [Related]
8. Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials.
Wei ZH; Wang H; Chen XY; Wang BS; Rong ZX; Wang BS; Su BH; Chen HZ
Eur J Clin Nutr; 2009 Jul; 63(7):821-7. PubMed ID: 18985059
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
Farnier M; Bonnefous F; Debbas N; Irvine A
Arch Intern Med; 1994 Feb; 154(4):441-9. PubMed ID: 8117177
[TBL] [Abstract][Full Text] [Related]
10. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
[TBL] [Abstract][Full Text] [Related]
11. The effect of beta-pyridylcarbinol on lipoprotein lipids in primary type IIa hyperlipoproteinemia.
Schwandt P; Weisweiler P; Neureuther G
Atherosclerosis; 1979 Sep; 34(1):35-9. PubMed ID: 227427
[TBL] [Abstract][Full Text] [Related]
12. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
[TBL] [Abstract][Full Text] [Related]
13. Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
Wechsler JG; Hutt V; Klör HU; Ditschuneit H
Artery; 1980; 8(6):519-29. PubMed ID: 7259531
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT
Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
[TBL] [Abstract][Full Text] [Related]
15. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
März W; Grützmacher P; Paul D; Siekmeier R; Schoeppe W; Gross W
Int J Clin Pharmacol Ther; 1994 Feb; 32(2):92-7. PubMed ID: 8004365
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
Arntz HR; Klemens UH; Vollmar LJ; Lang PD
Med Klin; 1978 Dec; 73(49):1731-7. PubMed ID: 723760
[TBL] [Abstract][Full Text] [Related]
17. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
Castaño G; Mas R; Fernández L; Illnait J; Gámez R; Alvarez E
Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of primary hyperlipoproteinemia types IIa, IIb and IV using beta pyridylcarbinol Study on three phases under ambulatory conditions].
Klemens UH; von Löwis P
Dtsch Med Wochenschr; 1973 Jun; 98(24):1197-202. PubMed ID: 4350685
[No Abstract] [Full Text] [Related]
19. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects.
Puccetti L; Bruni F; Bova G; Cercignani M; Palazzuoli A; Console E; Auteri A; Pasqui AL
Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):378-87. PubMed ID: 12055702
[TBL] [Abstract][Full Text] [Related]
20. [Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].
Ditschuneit HH; Dreyer M; Dammann HG; Ditschuneit H
Med Klin (Munich); 1991 Mar; 86(3):142-8. PubMed ID: 1903497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
